Yum Brands is preparing to release its latest earnings report Thursday, and all eyes will be on how much damage a growing cyclospora outbreak linked to Taco Bell has done to the fast-food giant’s most important revenue source.
The foodborne illness crisis has landed squarely in the lap of new Yum Brands CEO Chris Turner, who is facing his first significant test as company leader — coming just weeks after the firm announced it was selling off Pizza Hut for $2.7 billion. Investors will be watching closely for updates on customer traffic and what management intends to do to turn things around.
Taco Bell has been one of the company’s strongest performers, stringing together nearly six straight years of sales growth and accounting for close to half of Yum’s total operating profit in 2025. The chain’s appeal to budget-minded diners through affordable menu options had been a key driver of that success.
eMarketer analyst Rachel Wolff said investors are going to want specifics. “Investors will want detail on how Yum plans to win back trust and traffic, especially considering that the source of the outbreak hasn’t been fully nailed down and consumers overall remain wary of visiting QSR chains,” she said.
Since Taco Bell was first connected to the cyclosporiasis outbreak in early July, Yum’s stock has fallen roughly 8%, though some brand analysts believe the long-term damage to the chain’s reputation will be limited.
Health authorities are working to identify the exact source of what has become one of the largest foodborne illness outbreaks the United States has seen in recent years. Thousands of people across Michigan and eight other states have been sickened. The FDA has pointed to a Taylor Farms facility in Mexico as the source of the Cyclospora parasite.
Consumer Edge analyst Michael Gunther noted that sales figures at Taco Bell have fallen steeply in recent weeks, with daily revenue running more than 20% below typical levels for several days in a row. Foot traffic data from Placer.ai shows customer visits have declined every day since July 13, with a drop of 20.8% recorded on July 23 compared to the Thursday average from January 1 through July 6.
The earnings release will also give investors their first real look at Turner’s leadership under pressure. Turner, who was named CEO in October of last year and previously held positions at PepsiCo and consulting firm McKinsey & Co., is navigating the crisis while also trying to reignite the company’s broader growth strategy.
Michael Ashley Schulman, a partner at Cerity Partners, put it plainly: “Every new CEO gets a defining moment; Chris Turner is finding his sooner than most.”
Beyond the outbreak, Yum is also dealing with broader headwinds facing the fast-food industry. Persistent inflation has made consumers more careful with spending, and the rising popularity of GLP-1 weight-loss medications is nudging some people toward healthier food choices.
Analysts polled by LSEG expect the company to report second-quarter comparable sales growth of around 3% and an approximately 10% increase in adjusted profit. Yum typically stops short of offering detailed forward-looking guidance during investor calls.
Schulman offered a pointed reminder of what’s at stake for the new CEO: “Wall Street has a short memory for isolated setbacks and a long memory for poor execution; that’s the scorecard Chris Turner is playing against.”
